Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
published in: Journal of Clinical Oncology
date of publication: 2013-12-02
language: English
main subject: placebo, magnesium, neurotoxicity, oxaliplatin, toxic encephalopathy
Cites articles 16
Date
Title
Article - wd:Q37662241